000			04280nam a22006017a 4500
008			240723s20242024 xxu||||| |||| 00| 0 eng d
022			_a2052-4897
024			_a12/2/e003788 [pii]
024			_aPMC10936515 [pmc]
040			_aOvid MEDLINE(R)
099			_a38471671
245			_aPilot feasibility and efficacy of a strategy to sustain A1C improvement among diverse adults with type 2 diabetes completing a diabetes care management program.
251			_aBMJ Open Diabetes Research & Care. 12(2), 2024 Mar 11.
252			_aBMJ open diabetes res. care. 12(2), 2024 Mar 11.
253			_aBMJ open diabetes research & care
260			_c2024
260			_p2024 Mar 11
260			_fFY2024
265			_sepublish
265			_tMEDLINE
520			_aCONCLUSIONS: Among completers of a 3-month DCM program, a low intensity 9-month sustaining strategy maintained A1C under 8.0% (HEDIS (Healthcare Effectiveness Data and Information Set) threshold for diabetes control) compared with controls for 15 months after completion of the initial DCM intervention. Copyright © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
520			_aINTRODUCTION: Evidence-based strategies are needed to sustain improvements in outcomes following diabetes care management (DCM) programs. We examined the impact of Boot Camp-Plus (BC-Plus), an innovative sustaining strategy, on A1C among adults with type 2 diabetes completing a 3-month Diabetes Boot Camp (DBC). This health system sponsored program consisted of diabetes self-management education and support, medical nutrition therapy and antihyperglycemic medications management.
520			_aRESEARCH DESIGN AND METHODS: From March 2019 to July 2021, adult DBC completers with Medicare or a health system Medicaid or employee commercial plan were enrolled in BC-Plus for 9 months. DBC completers not meeting insurance eligibility or who declined to participate in BC-Plus acted as controls. During the first 3 months, BC-Plus participants received ongoing daily remote blood glucose (BG) monitoring; and during all 9 months, they received monthly check-in calls with BG review by a medical assistant who addressed needs for supplies/drugs, whether participants were checking BGs, and self-care encouragement. Escalation to a nurse practitioner occurred if the monthly BG trend was >200 mg/dL and/or several BG <80 mg/dL and/or new A1C >9.0% were identified. A1C was followed for an additional 9 months post-BC-Plus. A longitudinal mixed effects analysis was used to assess change in A1C from month 0 to month 21 of follow-up between BC-Plus participants versus controls.
520			_aRESULTS: A total of 838 DCM completers were identified, among whom 281 joined the BC-Plus intervention and 557 acted as controls. Mean age was 55.9 years; 58.2% were women; 66.2% were black; and 30.6% insured by Medicare. BC-Plus participants experienced significantly lower A1C compared with controls and remained below 8.0% to month 18.
546			_aEnglish
650			_a*Diabetes Mellitus, Type 2
650			_aAdult
650			_aAged
650			_aBlood Glucose/an [Analysis]
650			_aDiabetes Mellitus, Type 2/dt [Drug Therapy]
650			_aFeasibility Studies
650			_aFemale
650			_aGlycated Hemoglobin
650			_aHumans
650			_aMale
650			_aMedicare
650			_aMiddle Aged
650			_aUnited States
650			_zAutomated
651			_aMedStar Diabetes Institute
651			_aMedStar Health Research Institute
651			_aMedStar Washington Hospital Center
656			_aEndocrinology Fellowship
656			_aMedStar Georgetown University Hospital/MedStar Washington Hospital Center
657			_aJournal Article
700			_aAhmed, Saba _bMGUH _cEndocrinology Fellowship _dMD
700			_aMagee, Michelle _bMHRI
700			_aNassar, Carine M _bMWHC
790			_aMontero AR, Nassar CM, Ahmed S, Magee M
856			_uhttps://dx.doi.org/10.1136/bmjdrc-2023-003788 _zhttps://dx.doi.org/10.1136/bmjdrc-2023-003788
858			_yMagee, Michelle _uhttp://orcid.org/0000-0002-4692-3201 _zhttp://orcid.org/0000-0002-4692-3201
942			_cART _dArticle
999			_c14330 _d14330